(Q47680966)

4 February 2018

title

Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema (English)

1 reference

4 February 2018

Takumi Kiwamoto

0 references

Takashi Iizuka

1 reference

4 February 2018

Yukio Ishii

1 reference

4 February 2018

Ken Itoh

1 reference

4 February 2018

Toru Kimura

1 reference

4 February 2018

Yosuke Matsuno

1 reference

4 February 2018

Yuko Morishima

1 reference

4 February 2018

Ahmed E Hegab

1 reference

4 February 2018

Shinsuke Homma

1 reference

4 February 2018

Akihiro Nomura

1 reference

4 February 2018

Tohru Sakamoto

1 reference

4 February 2018

Masako Shimura

1 reference

4 February 2018

Aruto Yoshida

1 reference

4 February 2018

Masayuki Yamamoto

1 reference

4 February 2018

Kiyohisa Sekizawa

1 reference

4 February 2018

publication date

1 December 2005

1 reference

4 February 2018

published in

Genes to Cells

1 reference

4 February 2018

volume

1 reference

4 February 2018

issue

1 reference

4 February 2018

page(s)

1113-1125

1 reference

4 February 2018

Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Nrf2 is essential for protection against acute pulmonary injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Role of NRF2 in protection against hyperoxic lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Macrophage inflammatory proteins: biology and role in pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Role of antileukoprotease in the human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Salivary secretory leukocyte protease inhibitor increases in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Oxidative Stress in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Few smokers develop COPD. Why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Emphysema: the first two centuries--and beyond. A historical overview, with suggestions for future research: Part 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

The origins of a concept: the protease-antiprotease imbalance hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

Epidemiology of chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2005.00905.X

10.1111/J.1365-2443.2005.00905.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018